FDA inspection
Aeon Biotherapeutics Corp.: FDA inspection ending Mar 7, 2025
FDA inspection 1265004 · Voluntary Action Indicated (VAI) · New Taipei City
Key facts
| Inspection ID | 1265004 |
|---|---|
| Firm | Aeon Biotherapeutics Corp. |
| FEI number | 3019027610 |
| Address | Yingge District, 1f & 2f; No. 16, Ln. 658 Yingtano Rd. |
| City | New Taipei City |
| Country | Taiwan |
| Fiscal year | 2025 |
| Inspection end date | Mar 7, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data